Dianthus Therapeutics (DNTH) EBIT (QoQ) (2017 - 2025)
Dianthus Therapeutics (DNTH) EBIT (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -15.35% |
| Jun 30, 2025 | -5.27% |
| Mar 31, 2025 | -3.95% |
| Dec 31, 2024 | -6.74% |
| Sep 30, 2024 | -34.66% |
| Jun 30, 2024 | -24.43% |
| Mar 31, 2024 | -37.73% |
| Dec 31, 2023 | 17.79% |
| Sep 30, 2023 | -33.82% |
| Jun 30, 2023 | -53.27% |
| Mar 31, 2023 | 28.15% |
| Dec 31, 2022 | -29.55% |
| Sep 30, 2022 | 54.35% |
| Jun 30, 2022 | 24.13% |
| Mar 31, 2022 | -18.34% |
| Dec 31, 2021 | -10.39% |
| Sep 30, 2021 | -3.61% |
| Jun 30, 2021 | 5.81% |
| Mar 31, 2021 | 1.93% |
| Dec 31, 2020 | -3.72% |